✦ LIBER ✦

Immunological monitoring of in vitro and in vivo immune responses to the Ii-Key/HER2/neu MHC class II peptide vaccine in a phase I clinical trial in breast cancer patients

✍ Scribed by S. Khoo; C.E. Storrer; K.A. Harris; Y.H. Jama; Z.A. Dehqanzada; C.D. Shriver; E. von Hofe; S. Ponniah; G.E. Peoples Jr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early results of a phase I clinical tria

✍ Steven Khoo; Catherine Storrer; Katie Harris; Yusuf Jama; Anna Smith; Zia Dehqan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Clinical and Immunologic Responses of HL

✍ Ritesh Patil; Guy T. Clifton; Jarrod P. Holmes; Asna Amin; Mark G. Carmichael; J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 728 KB

Immunological monitoring of regulatory T

✍ Matthew T. Hueman; Steven Khoo; Catherine Storrer; Katie Harris; Yusuf Jama; Cra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB

The relationship between immunologic res

✍ Alan K. Sears; Guy T. Clifton; Linda C. Benavides; Jeremy D. Gates; Jarrod P. Ho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 97 KB

A more sensitive immunological monitorin

✍ Matthew T. Hueman; Jennifer Gurney; Michael Woll; Catherine Storrer; David McLeo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 53 KB

950 RESULTS FROM THE FIRST PHASE I CLINI

✍ S. Mpisias; T. Karaolides; A. Pappas; E. Koutsiaris; A. Konandreas; S. Perez; V. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 96 KB